0001415889-17-000308.txt : 20170223
0001415889-17-000308.hdr.sgml : 20170223
20170223180124
ACCESSION NUMBER: 0001415889-17-000308
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170221
FILED AS OF DATE: 20170223
DATE AS OF CHANGE: 20170223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moore Terrence O
CENTRAL INDEX KEY: 0001454276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 17633985
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-02232017_030207.xml
X0306
4
2017-02-21
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001454276
Moore Terrence O
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
false
true
false
false
EVP, CHIEF COMMERCIAL OFFICER
Common Stock
2017-02-21
4
M
0
7856
34.45
A
9527
D
Common Stock
2017-02-21
4
S
0
7856
39.65
D
1671
D
Stock Option (right to buy)
34.45
2017-02-21
4
M
0
7856
0
D
2025-03-19
Common Stock
7856
82500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016. All sales under the trading plan have been completed.
25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
/s/ Elizabeth Carter, Attorney-in-Fact
2017-02-23